CMS Open Payments · Program Year 2024
Heartflow, Inc.
Heartflow, Inc. reported $15,997,291.70 across General Payments, Research, and Ownership to 9,587 physicians and teaching hospitals across 9,638 transactions.
- $16.0M Top 10% payer
- All-tracks total
- 9,638 Top quartile volume
- Transactions
- 9,587 Top quartile reach
- Recipients
- +$714.6K
- General Payments vs PY2023
Heartflow, Inc. reported $15,997,291.70 across all CMS Open Payments tracks (General + Research + Ownership) to 9,587 physicians and teaching hospitals in Program Year 2024 - ranking #118 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $1,719,876.27, averaging $1.7K per recipient.
How Heartflow, Inc.'s $16.0M all-tracks total breaks down
Heartflow, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
B
88/100
Total payments
A
100/100
Transaction volume
B
80/100
Physician reach
B
83/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer heartflow-inc Heartflow, Inc.
$16.0M · #118/1,925 · 0.1% industry · PY2024
- TOT $16.0M
- RANK #118
- SHARE 0.1%
- TXN 9,638
- RCP 9,587
- CAT 7
- GEN $1.7M
- ΔGEN +$714.6K
- TOP1 6.2%
- PY 2024
Volume peers
Nearest volume peer: American Rheumatology Network, LLC ($15.9M)
Heartflow, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Heartflow, Inc.'s CMS-reported General Payments increased by $714.6K (+71.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: HEARTFLOW, INC.PY2023: HEARTFLOW, INC.PY2024: HEARTFLOW, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,005,315.59
- PY2024
- $1,719,876.27
What the Data Shows for Heartflow, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Heartflow, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 7-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $733.0K, accounting for 42.6% of this company's General Payments and 338 transactions.
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Heartflow, Inc.'s 7-category general-payment breakdown at $733.0K, 42.6% of the reported total.
Heartflow, Inc. reports 7 general-payment categories - the top three are Compensation for Services Other Than Consulting (42.6%), Food and Beverage (25.9%), and Consulting Fee (15.7%). The remaining 4 categories make up 15.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Heartflow, Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $733.0K | 338 | 42.6% |
| Food and Beverage | $445.1K | 8,757 | 25.9% |
| Consulting Fee | $270.5K | 159 | 15.7% |
| Education | $148.7K | 20 | 8.6% |
| Travel and Lodging | $88.6K | 299 | 5.2% |
| Space Rental or Facility Fees | $21.0K | 10 | 1.2% |
| Grant | $13.0K | 4 | 0.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $376,912.69 (21.9%) of $1,719,876.27 in this company's General Payments records across 5,245 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Heartflow, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Sarah Rinehart
$105,858.72 across 101 reported transactions
- 2
Atrium Health Cabarrus
$75,650.00 across 11 reported transactions
- 3
Mark Rabbat
$67,002.14 across 40 reported transactions
- 4
Michael Gallagher
$66,759.99 across 28 reported transactions
- 5
Jamaluddin Moloo
$61,641.84 across 49 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Heartflow, Inc. ranks #118 of 1,925 by total payments (top 6% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,618 of 1,838 by HHI (bottom 12% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Merz Pharmaceuticals, LLC : $919.5K total payments, HHI 162
- Vanda Pharmaceuticals Inc. : $4.6M total payments, HHI 160
- CeQur Corporation : $420.1K total payments, HHI 160
- Kiniksa Pharmaceuticals International, plc : $1.7M total payments, HHI 159
- Lundbeck LLC : $4.1M total payments, HHI 159
- Foundation Fusion Solutions, LLC : $106.1K total payments, HHI 157
- Heartflow, Inc. (this company) : $1.7M total payments, HHI 157
- Globus Medical, Inc. : $27.0M total payments, HHI 156
- Saxum Surgical, Inc. : $48.5K total payments, HHI 156
- Legacy Ortho LLC : $39.6K total payments, HHI 155
- Spineart USA Inc : $830.2K total payments, HHI 154
- Medimetriks Pharmaceuticals, Inc. : $35.9K total payments, HHI 152
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Heartflow, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Heartflow, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Heartflow, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
SPR Therapeutics, Inc
Organon Llc
Bausch & Lomb Americas Inc.
Philips North America LLC
Aveo Pharmaceuticals, Inc.
Put this to use
Heartflow, Inc. ranks #118 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Heartflow, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Heartflow, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.